The current CE lesson by Jennifer LaPreze, PharmD, BCACP, CDCES, CPP, et al titled “Evolving Therapies for Metabolic Liver Disease” describes nonalcoholic fatty liver disease and a newly approved medication to target advanced cases. Nonalcoholic fatty liver disease is growing in prevalence in Western countries, due in part to the increase in obesity. In recent years, liver experts have pushed to revise how liver disease is classified to stress the importance of the links between the condition and metabolism. That connection led to treatment recommendations that stress diet and lifestyle. On the medication front, in 2024 resmetirom became the first drug of its kind engineered to treat advanced metabolic liver disease.
This lesson instructs pharmacists how to distinguish between old and new nomenclature; understand the pathophysiology for metabolic liver disease; review the risk factors and diagnostic tools for metabolic liver disease; and recognize the pharmacologic and nonpharmacologic treatment options for metabolic liver disease.
In the November issue, which is the Diabetes focus, a continuing education lesson by Yvette C. Terrie, BS Pharm, RPh, will present an overview of the American Diabetes Association’s Standards of Care in Diabetes—2004. Updates to the 2024 Standards of Care include new recommendations to achieve improved quality of care and better clinical outcomes.
The incidence and prevalence of diabetes and prediabetes are continuing to climb in the United States. Pharmacists play a key role in diabetes care, and the updated guidelines are designed to help them implement effective patient-centered treatment plans. As described in this CE, early diagnosis, clinical intervention, and patient adherence are crucial for effective diabetes management, which also involves pharmacologic and nonpharmacologic treatments tailored to the patient’s needs.
Looking ahead, the December issue will feature a new CE lesson tentatively titled “Triage and Assessment of Common GI Topics in the Community Setting.” Jared Ostroff, PharmD, MBA, BCACP, et al will cover gastrointestinal (GI) topics that are often encountered in the community pharmacy. Pharmacists can learn to use frameworks such as QuEST and the SCHOLAR Process to help triage these individuals to address common GI topics, such as nausea and vomiting, diarrhea, constipation, need for bowel prep, heartburn, and bloating/gas relief.
In general, the subject matter of CE lessons in U.S. Pharmacist aligns with the particular issue focus.
The content contained in this article is for informational purposes only. The content is not intended to be a substitute for professional advice. Reliance on any information provided in this article is solely at your own risk.
